Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07340411Phase 2Recruiting
Phase 2, randomised trial of Chinese herbal medicine oral spray in chronic rhinosinusitis (CRS) (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: Taiwanese version of the 22-item Sino-Nasal Outcome Test and Self-reported adverse events at 2 months. Started Jul 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07340411.